Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Biotech Valuations Are Down, But Merck Keeps Doing Deals
02:20pm, Thursday, 27'th Oct 2022
Merck CFO Caroline Litchfield says her firm had a busy quarter of business development, announcing a personalized cancer vaccine.
Merck & Co., Inc. (MRK) Q3 2022 Earnings Call Transcript
12:30pm, Thursday, 27'th Oct 2022
Merck & Co., Inc. (NYSE:MRK ) Q3 2022 Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Rob Davis - President and Chief Ex
Merck Stock Hits A Fresh High After Third-Quarter Beat, But Is It A Buy?
12:06pm, Thursday, 27'th Oct 2022
Is Merck stock a buy after the company notched a third-quarter beat and raised guidance for 2022? Is MRK stock a buy now?
Merck (MRK) Q3 Earnings and Revenues Surpass Estimates
09:02am, Thursday, 27'th Oct 2022
Merck (MRK) delivered earnings and revenue surprises of 10.78% and 6.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Merck Outmaneuvers Exchange-Rate Headwinds For A Bullish Beat-And-Raise
08:51am, Thursday, 27'th Oct 2022
Merck stock jumped Thursday after the company beat third-quarter forecasts and raised its full-year guidance despite exchange-rate struggles. The post Merck Outmaneuvers Exchange-Rate Headwinds For A
Merck CEO Robert Davis on earnings: We have strong momentum across key growth drivers
08:11am, Thursday, 27'th Oct 2022
Merck CEO Robert Davis joins CNBC's 'Squawk Box' to break down the company's third-quarter earnings report, which beat Wall Street's estimates on Thursday.
Merck Q3 earnings top Wall Street's expectations
07:14am, Thursday, 27'th Oct 2022
CNBC's 'Squawk Box' team breaks down Merck's third-quarter earnings report, which beat Wall Street's expectations on the top and bottom lines.
Merck stock rises after profit and sales beat, raised outlook
06:46am, Thursday, 27'th Oct 2022
Shares of Merck & Co. Inc. MRK, +0.72% rose 1.4% in premarket trading Thursday, after the drug giant reported third-quarter profit and sale that beat expectations and raised its full-year outlook, as
Is Merck Moving Toward Another Blockbuster Drug Launch?
09:53am, Wednesday, 26'th Oct 2022
Merck will soon share its positive phase 3 clinical trial results for a rare disease drug candidate at an upcoming event.
DeepMatter sees 50% growth in full-year revenue and inks multi-year licence deal with Merck
04:38am, Wednesday, 26'th Oct 2022
DeepMatter Group PLC (AIM:DMTR), the digital chemistry data and software company, announced a multi-year database licence agreement with Merck & Co Inc (NYSE:MRK) and forecast strong revenue growth f
Will Merck Stock Rise After Its Q3 Results?
08:00am, Tuesday, 25'th Oct 2022
Merck's top-selling drug - Keytruda - saw its sales rise 26% to $5.3 billion in Q2, while Gardasil sales were up a significant 36% to $1.7 billion.
Merck: A Shield From Recession
07:39pm, Monday, 24'th Oct 2022
Merck has proven to be a resilient healthcare business that has provided growth, while the share price hasn't moved all that much. This year that has changed, and Merck shares are rising above peers w
7 Stocks to Sell Before They Give Back This Year's Gain
07:12am, Monday, 24'th Oct 2022
I'm generally the positive type. Still, as I look at the market, the math isn't on my side.
IBD's Three Best ESG Companies In Eight Industry Categories For 2022
07:00am, Monday, 24'th Oct 2022
Investors active in ESG investing consider a company's corporate values and environmental practices. But they're also seeking to buy the best ESG stocks, those that make solid returns.
Stocks This Week: Buy Merck And Eli Lilly
06:00am, Monday, 24'th Oct 2022
This is likely the last bearish week before a rally runs through the next two months.
